Regulation of spermidine/spermine N1-acetyltransferase expression by cytokines and polyamines in human hepatocarcinoma cells (HepG2)

✍ Scribed by M. Alfonsina Desiderio; Giovanna Pogliaghi; Paola Dansi

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 291 KB
• Volume: 174
• Category: Article
• ISSN: 0021-9541
• DOI: 10.1002/(sici)1097-4652(199801)174:1<125::aid-jcp14>3.0.co;2-e

✦ Synopsis

Spermidine/spermine N 1 -acetyltransferase (cSAT), a key enzyme in polyamine degradation, is induced by various hepatotoxins and liver tumor promoters. In this paper we demonstrate that physiological factors, such as cytokines, control cSAT expression in HepG2 human hepatocarcinoma cells. Hepatocyte growth factor (HGF) induced the cSAT mRNA precursor (3.5 kb) at 4 h. The mature form of mRNA (1.3 kb) increased 6-8-fold between 8 and 10 h, and remained elevated until 18 h. An increase in cSAT activity (2-fold) and high levels of N 1 -acetylspermidine were observed concomitantly. Interleukin-1b (IL-1b) enhanced cSAT expression (both mRNA and enzyme activity) similar to HGF, while tumor necrosis factor-a (TNFa) was less effective. This system also provides a useful means for examining the involvement of negative and positive changes of polyamines in the induction of cSAT and c-jun, a gene that participates in the control of cSAT expression. a-Difluoromethylornithine (DFMO) pretreatment, by lowering putrescine and spermidine in HGF-or IL-1b-treated cells, prevented the induction of cSAT. This effect was reversed by exogenous putrescine or spermidine. IL-1b induced c-jun mRNA more than HGF. DFMO prevented almost completely the enhancement of c-jun mRNA expression by IL-1b, and this effect was reversed by exogenous putrescine or spermidine. Therefore, we suggest that cSAT and c-jun expression is specifically regulated by polyamine-mediated mechanisms in IL-1b treated HepG2 cells. Since cSAT is inducibile by cytokines that control tumor metabolism and growth as well as tumor-host interaction, we hypothesize an involvement of cSAT in hepatoma growth.